Drug intelligence / Profile preview

simethicone

Development stage
Phase 4
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Simethicone is an orally administered anti-foaming agent used to alleviate symptoms associated with excessive gastrointestinal gas, such as bloating, pressure, and flatulence. It functions as a surfactant by decreasing the surface tension of gas bubbles within the digestive tract, causing them to coalesce into larger bubbles that are more easily expelled via belching or flatus. Beyond its use as an over-the-counter treatment for dyspepsia and infantile colic, simethicone is widely utilized in clinical gastroenterology as an adjunct to bowel cleansing regimens (e.g., polyethylene glycol) prior to colonoscopy or capsule endoscopy. By eliminating foam and bubbles that can obscure the mucosal surface, it enhances visualization quality and may reduce the need for intraprocedural flushing, thereby potentially lowering the risk of endoscope-associated infections. Simethicone is chemically inert and not absorbed into the bloodstream, making it suitable for use in both pediatric and adult populations.

Brand names
Gas-XMyliconPhazymeMaalox Anti-GasMylanta GasInfacolWind-EzeImodium Multi-Symptom Relief
Other names
activated dimeticonedimethylpolysiloxanedimethylpolysiloxane silicon dioxide mixtureactivated methylpolysiloxane
02

Targets

Gas–liquid interfaces / foam films in the gastrointestinal lumen

Beyond the preview

Go deeper on simethicone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on simethicone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call